Literature DB >> 25470142

US lung cancer trends by histologic type.

Manali I Patel1, Iona Cheng, Scarlett Lin Gomez.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25470142      PMCID： PMC5746178          DOI： 10.1002/cncr.29180

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.921


× No keyword cloud information.
  4 in total

1.  Health outcomes among Hispanic subgroups: data from the National Health Interview Survey, 1992-95.

Authors:  A Hajat; J B Lucas; R Kington
Journal:  Adv Data       Date:  2000-02-25

2.  Use of multiple imputation to correct for bias in lung cancer incidence trends by histologic subtype.

Authors:  Mandi Yu; Eric J Feuer; Kathleen A Cronin; Neil E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-22       Impact factor: 4.254

3.  US lung cancer trends by histologic type.

Authors:  Denise Riedel Lewis; David P Check; Neil E Caporaso; William D Travis; Susan S Devesa
Journal:  Cancer       Date:  2014-08-11       Impact factor: 6.860

4.  International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising.

Authors:  Susan S Devesa; Freddie Bray; A Paloma Vizcaino; D Max Parkin
Journal:  Int J Cancer       Date:  2005-11-01       Impact factor: 7.396
  4 in total
  10 in total

1.  HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.

Authors:  Honghong Jiang; Qiaofen Fu; Xin Song; Chunlei Ge; Ruilei Li; Zhen Li; Baozhen Zeng; Chunyan Li; Ying Wang; Yuanbo Xue; Rongcheng Luo; Weiyi Fang
Journal:  Oncol Lett       Date:  2019-09-05       Impact factor: 2.967

2.  Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance.

Authors:  Chuanfen Zhang; Chunmei Wang; Zhenyu Yang; Yuquan Bai; Takehito Shukuya; Mau-Ern Poh; Simon Ekman; Jian Li; Yuyang Xu; Senyi Deng
Journal:  Transl Lung Cancer Res       Date:  2022-05

3.  Racial and Ethnic Variations in Lung Cancer Incidence and Mortality: Results From the Women's Health Initiative.

Authors:  Manali I Patel; Ange Wang; Kristopher Kapphahn; Manisha Desai; Rowan T Chlebowski; Michael S Simon; Chloe E Bird; Giselle Corbie-Smith; Scarlett Lin Gomez; Lucile L Adams-Campbell; Michele L Cote; Marcia L Stefanick; Heather A Wakelee
Journal:  J Clin Oncol       Date:  2015-12-23       Impact factor: 44.544

4.  Decreased expression of EFCC1 and its prognostic value in lung adenocarcinoma.

Authors:  Liang Xia; Yunke Zhu; Chuanfen Zhang; Senyi Deng; Yulan Deng; Zhenyu Yang; Jiandong Mei; Lunxu Liu
Journal:  Ann Transl Med       Date:  2019-11

5.  Differential protein-coding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma.

Authors:  Shicheng Li; Xiao Sun; Shuncheng Miao; Jia Liu; Wenjie Jiao
Journal:  Thorac Cancer       Date:  2017-09-26       Impact factor: 3.500

6.  Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015.

Authors:  Yu Jie Zhong; Yi Feng Wen; Hai Ming Wong; Guosheng Yin; Ruitao Lin; Shuan Ying Yang
Journal:  Front Oncol       Date:  2019-05-31       Impact factor: 6.244

7.  Knockdown of mitochondrial threonyl-tRNA synthetase 2 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.

Authors:  Hui Tian; Hao Yan; Yong Zhang; Qiaofen Fu; Chunyan Li; Juan He; Hui Li; Yong Zhou; Youguang Huang; Rongqing Li
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

8.  MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha.

Authors:  Gang Chen; Qihao Wang; Kunyu Wang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

9.  Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening.

Authors:  Zhichao Li; Youhui Qian; Wujiao Li; Lisa Liu; Lei Yu; Xia Liu; Guodong Wu; Youyu Wang; Weibin Luo; Fuyuan Fang; Yuchen Liu; Fei Song; Zhiming Cai; Wei Chen; Weiren Huang
Journal:  iScience       Date:  2020-07-25

10.  Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma.

Authors:  Chang-Shuai Zhou; Ming-Tao Feng; Xin Chen; Yang Gao; Lei Chen; Liang-Dong Li; De-Heng Li; Yi-Qun Cao
Journal:  Onco Targets Ther       Date:  2021-02-15       Impact factor: 4.147
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.